4//SEC Filing
Teso-Lichtman Leslie 4
Accession 0001140361-22-024487
CIK 0001092662other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:00 PM ET
Size
8.2 KB
Accession
0001140361-22-024487
Insider Transaction Report
Form 4
Teso-Lichtman Leslie
Director
Transactions
- Award
Restricted stock units
2022-06-27+64,000→ 64,000 total→ Common stock (64,000 underlying) - Award
Nonqualified stock options
2022-06-27+82,286→ 82,286 totalExercise: $1.25Exp: 2032-06-26→ Common stock (82,286 underlying)
Footnotes (4)
- [F1]Awards were granted in connection with the initial election of the reporting person to the board of directors of the issuer, which occurred at the issuer's 2022 annual meeting of stockholders on May 24, 2022. The grants of the awards were deferred until a sufficient number of reserved shares of common stock had become available for grant under the 2019 Omnibus Incentive Plan of the issuer.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]The restricted stock units are scheduled to vest in three equal installments immediately prior to the 2023, 2024 and 2025 annual meetings of stockholders of the issuer, or shall vest in full upon a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer).
- [F4]The nonqualified stock options are scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2023 annual meeting of stockholders of the issuer and (ii) a Change in Control.
Documents
Issuer
CHEMBIO DIAGNOSTICS, INC.
CIK 0001092662
Entity typeother
Related Parties
1- filerCIK 0001925067
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:00 PM ET
- Size
- 8.2 KB